PATENT CLAIM ANALYSIS

Application Number: 16178334
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "236100"]

Abstract:
A method for treating an abnormality of the first metatarsophalangeal joint of the foot of a mammal includes electrically stimulating a site on each of the extensor hallucis brevis and adductor hallucis muscles of a foot of the mammal affected by the abnormality, and visually confirming that the stimulated muscles responds to the stimulation by contracting. An amount of botulinum toxin effective to treat the abnormality is then injected to the confirmed sites on the extensor hallucis brevis and the adductor hallucis muscles of the affected foot.

Claim (Index 8):
The method of  claim 7 , further comprising electrically stimulating a fourth site, which is on the lateral head of the flexor hallucis brevis muscle, and visually confirming that the stimulated flexor hallucis brevis muscle responds to stimulating at the fourth site by contracting.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.83673
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15917492', '11056382', '11504198', '12748404', '14791389']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7153737688377496
- 35 USC 102 Novelty (BERT): 0.6667313090188502
- Combined Prediction Score: 0.7105095228558597
- Mean Citation Score: 444.17166
- Max Citation Score: 839.7275400000003
- Similarity Product: 603.3139213986972

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test